patients who survived
[용어속성] Patient
Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study
Observational Study
[키워드] Affect
age
Analysis
applied
arrythmia
clinical history
Cohort
collected
conducted
COVID
COVID-19
COVID-19 case
death
died
discharge
Effect
emergency service
emergency services
Factor
Fever
First wave
Follow-up
follow-up study
Frequency
headache
hospital
Hospitalization
Hospitalized
identification
identify
information
Long
Long COVID
main outcome measure
Measures
men
mental health
multicentre
multiple logistic regression
neurological
outcome
Pain
pandemic
Patient
patients
patients who survived
PCR-confirmed
performed
persistent symptoms
Pneumonia
Post-discharge
primary care
provided
readmission
reported
required
Result
returned
SARS-CoV-2
Sequelae
Severe case
Sex
Spain
SPS
supplementary material
Symptom
Thoracic
[DOI] 10.1186/s12916-021-02003-7 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1186/s12916-021-02003-7 PMC 바로가기 [Article Type] Observational Study
Presentation and Outcome of Coronavirus Disease (COVID-19) in Patients at a Geriatric Psychiatric Outpatient Clinic
Conference abstract
Published on
Journal: The American journal of geriatric psychiatry : official journal of the [Category] 유전자 메커니즘,
Journal: The American journal of geriatric psychiatry : official journal of the [Category] 유전자 메커니즘,
[키워드] Affect
age
baseline
clinic
clinical
Cohort
Comorbidities
COVID-19
COVID-19 infection
death
demographic characteristics
diagnosed with COVID-19
died
disorder
Elderly patient
Electronic health records
evaluate
exposure to
Factor
Fisher
funding
Future
Gender
identify
immune response
impression
increased mortality
increased risk
indicated
information
majority
mechanism
morbidity and mortality
Mortality
Neuropsychiatric
New York
NIH
novel coronavirus disease
observation
older patient
Outpatient
outpatient clinic
Patient
patients
patients who survived
presentation
problem
provided
Psychiatric
psychiatrist
psychiatry
reported
Result
retrospective
returned
risk factor
Risk factors
survived
t-test
those who survived
[DOI] 10.1016/j.jagp.2021.01.099 [Article Type] Conference abstract
[DOI] 10.1016/j.jagp.2021.01.099 [Article Type] Conference abstract
Association between red blood cell distribution width and mortality and severity among patients with COVID-19: A systematic review and meta-analysis
COVID-19 환자의 적혈구 분포 폭과 사망률 및 중증도의 연관성: 체계적인 검토 및 메타 분석
Meta-Analysis
[키워드] 95% CI
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Admission
adverse outcome
adverse outcomes
association
Biomarker
Biomarkers
Blood
blood cell
Cell
Clinical outcome
clinical outcomes
Control
coronavirus
COVID-19
COVID-19 patient
COVID-19 patients
COVID-19 severity
died
disease severity
disease severity of COVID-19
distribution
erythrocyte
erythrocyte indices
Evidence
inception
less
mean differences
Meta-analysis
Mortality
on admission
pathophysiology
Patient
patients hospitalized
patients who survived
plasma
Prognosis
red blood cell
red blood cell distribution width
Research
respiratory
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severe symptoms
severely ill COVID-19 patients
severity
subject
Symptom
systematic review
was performed
with COVID-19
[DOI] 10.1002/jmv.26797 PMC 바로가기 [Article Type] Meta-Analysis
[DOI] 10.1002/jmv.26797 PMC 바로가기 [Article Type] Meta-Analysis
Safety and Efficacy of Convalescent Plasma in Elderly COVID-19 Patients: The RESCUE Trial
Research article
[키워드] acute respiratory syndrome
administration
Adverse reaction
Antibody titer
C-reactive protein
Care
clearance
control group
convalescent plasma
coronavirus
Coronavirus disease 2019
COVID-19
COVID-19 infection
COVID-19coronavirus disease 2019
CPconvalescent plasma
CRPC-reactive protein
effective
Efficacy
elderly
Elderly patient
eliminating
enrolled
FiO2fraction of inspired oxygen
Follow-up
fraction of inspired oxygen
functional
greater
IL-6interleukin 6
Immunity
improvement
Infection
interleukin 6
interquartile range
IQRinterquartile range
ISSItalian National Institute of Health
Italian National Institute of Health
Italy
laboratory parameter
lombardy
Long-term care facility
LTCFlong-term care facility
median
moderate
Neutralizing antibody titer
NNTnumber needed to treat
not significant
NSnot significant
number needed to treat
objective
overall mortality
Patient
patients who survived
PCRpolymerase chain reaction
polymerase chain reaction
progression
prospective cohort study
radiologic
Real-time Evaluation of Safety and Efficacy of Convalescent Plasma Units Transfused to Elderly Patients With COVID-19
recorded
reduction in mortality
Registration
RESCUEReal-time Evaluation of Safety and Efficacy of Convalescent Plasma Units Transfused to Elderly Patients With COVID-19
Result
risk
Safe
Safety
SARS-CoV-2severe acute respiratory syndrome coronavirus 2
severe acute respiratory syndrome coronavirus 2
severe coronavirus disease
survival
symptomatic patient
transfused
Treatment
virus
were assessed
were given
were recorded
with COVID-19
[DOI] 10.1016/j.mayocpiqo.2021.01.010 [Article Type] Research article
[DOI] 10.1016/j.mayocpiqo.2021.01.010 [Article Type] Research article
Comparing the Value of Cystatin C and Serum Creatinine for Evaluating the Renal Function and Predicting the Prognosis of COVID-19 Patients
Pharmacology
[키워드] abnormality
adjusted
Admission
analyses
Analysis
association
changes in
characteristic
Chronic kidney disease
Clinical characteristics
clinical variables
COVID-19
COVID-19 patient
COVID-19 patients
Cox regression
creatinine
cystatin C
death
died
disease
disease severity
elevated
evaluate the effect
evaluated
Evaluating
flat
function
independent predictor
Kaplan–Meier
Logistic
occur
Patient
patients who survived
performed
poor prognosis
Predictive
Prognosis
Prognostic value
renal function
rising
risk
ROC
ROC Curve
serum creatinine
survival
survival curve
two groups
value
[DOI] 10.3389/fphar.2021.587816 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2021.587816 PMC 바로가기 [Article Type] Pharmacology
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients
입원한 COVID-19 환자의 혈액 인터페론-α 수준 및 중증도, 결과 및 염증 프로필
Immunology
[키워드] association
Blood
blood lymphocyte
blood sample
Blood samples
clinical
clinical condition
clinical manifestation
clinical manifestations
clinically
Cohort
conditions
Control
control patient
controls
COVD-19
COVID-19
COVID-19 patient
COVID-19 severity
COVID−19
Deficient
defined
detectability
died
each time-point
enrolled
Enrollment
evaluate
Evolution
expression
hospitalized patient
identify
IFN-α
IFN-β
IL-10
Immune cell
immune cells
Immune profile
immunoassay
immunological pathway
immunological pathways
improvement
Infection
interferon
interferon response
Intervention
Level
Lymphocytes
manifestation
matched controls
mechanism
mediators
Mortality
multiplex
Patient
patients who survived
pharmacological
profile
proportion
Prospective Study
recruitment
required
respiratory
Respiratory failure
Respiratory Support
SARS-COV-2 infection
SARS–CoV−2
severe manifestations of COVID-19
severity
significant increase
study period
study population
subjects
survived
survivor
target
the interferon
threshold
were assessed
[DOI] 10.3389/fimmu.2021.648004 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.648004 PMC 바로가기 [Article Type] Immunology
Neutrophil Extracellular Traps in SARS-CoV2 Related Pneumonia in ICU Patients: The NETCOV2 Study
Medicine
[키워드] acute respiratory syndrome
Analysis
association
Blood
Blood level
Coagulation
Concentration
coronavirus
COVID-19 patients
COVID19
decrease
defined
described
died
disease
Extracellular
extracellular trap
flow cytometry
Hypoxemia
ICU
ICU admission
Infectious disease
Inflammatory
inflammatory status
intensive care
lack
male
median
Mortality
multivariable
NET
NETs
neutrophils extracellular traps neutrophils extracellular traps
PaO
pathway
Patient
patients who survived
Pneumonia
Primary outcome
quantification
quantified
remained
Respiratory failure
SARS-CoV-2
SARS-CoV2
severe hypoxemia
significantly
therapeutic target
Whole blood
whole blood sample
[DOI] 10.3389/fmed.2021.615984 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.615984 PMC 바로가기 [Article Type] Medicine
Clinical Determinants Differentiating the Severity of SARS-CoV-2 Infection in Cancer Patients: Hospital Care or Home Recovery
Medicine
[키워드] Analysis
anti-cancer treatment
Antibody test
Asymptomatic
asymptomatic patient
baseline
Cancer
Cancer center
Cancer patients
Care
Chemotherapy
clinical
clinical factor
Community
composed
conducted
COVID-19
cumulative
Deceased
described
determinant
diagnosed
died
discharged patient
group
home
hospital
Hospital stay
Hospitalization
Hospitalized
hospitalized patient
hospitalized patients
Immunosuppression
intubation
median
median age
moderate
Mortality
MOST
New York City
older patient
outcome
Patient
patients who survived
performance status
positive
predict
previous study
receiving
required
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 RNA
survived
symptomatic
symptomatic patient
Symptoms
therapy
trajectory
Treatment
treatment of negative impact
virus
worse prognosis
[DOI] 10.3389/fmed.2021.604221 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.604221 PMC 바로가기 [Article Type] Medicine
Association between Clinical Characteristics and Laboratory Findings with Outcome of Hospitalized COVID-19 Patients: A Report from Northeast Iran
Research Article
[키워드] Admission
admitted to ICU
age
association
C-reactive protein (CRP
Characteristics
chest pain
China
clinical
clinician
Coronavirus disease 2019
correlation
COVID-19
CRP
CRP level
Decreased
duration of hospitalization
Dyspnea
early diagnosis
erythrocyte sedimentation rate
ESR
evaluated
Evaluating
help
hospital
Hospitalization
hospitalized COVID-19 patient
ICU
Imam
intensive care
Iran
Laboratory
laboratory feature
laboratory finding
management
medical record
mortality rate
nonsurvivor
nonsurvivors
outcome
Pain
Patient
patients who survived
patients with COVID-19
Predictive
predictor
Prognosis
report
Reza
risk
Sex
significantly
significantly higher
Spread
statistically
survivor
variable
was determined
WBC
White blood cell
[DOI] 10.1155/2021/5552138 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1155/2021/5552138 PMC 바로가기 [Article Type] Research Article